0001493152-19-007624.txt : 20190516 0001493152-19-007624.hdr.sgml : 20190516 20190516131204 ACCESSION NUMBER: 0001493152-19-007624 CONFORMED SUBMISSION TYPE: AW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20190516 DATE AS OF CHANGE: 20190516 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NEPHROS INC CENTRAL INDEX KEY: 0001196298 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 133971809 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: AW SEC ACT: SEC FILE NUMBER: 333-205169 FILM NUMBER: 19831576 BUSINESS ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 BUSINESS PHONE: 201.343.5202 MAIL ADDRESS: STREET 1: 380 LACKAWANNA PLACE CITY: SOUTH ORANGE STATE: NJ ZIP: 07079 AW 1 aw.htm

Nephros, Inc.

380 Lackawanna Place

South Orange, New Jersey 07079

(201) 343-5202

May 16, 2019

VIA EDGAR

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Timothy Buchmiller

	Re:	Nephros, Inc. (the “Company”)
		Post-Effective Amendment to Registration Statement on Form S-1
		File No. 333-205169

Dear Mr. Buchmiller:

Pursuant to Rule 477 under the Securities Act of 1933, as amended (the “Securities Act”), Nephros, Inc. (the “Registrant”), hereby requests withdrawal, effective immediately, of the Post-Effective Amendment (the “Amendment”) to its Registration Statement on Form S-1 (File No. 333-205169) (the “Registration Statement”), together with all exhibits thereto.

The Registrant separately filed a Post-Effective Amendment to Registration Statement on Form S-1 (File No. 333-225109) that, pursuant to Rule 429 under the Securities Act, also constituted a post-effective amendment to the Registration Statement. Accordingly, the Amendment has been superseded.

The Amendment was initially filed with the Securities and Exchange Commission on May 9, 2019. No securities were sold pursuant to the Amendment, and the Amendment was never declared effective.

Please contact Amanda Lorentz of Fredrikson & Byron, P.A. at (612) 492-7403 if you have any questions.

	Sincerely,

	Nephros, Inc.

	By:	/s/ Daron Evans
		Daron Evans
		Chief Executive Officer